{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T17:08:04Z","timestamp":1780506484832,"version":"3.54.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["Grants 82260957"],"award-info":[{"award-number":["Grants 82260957"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["Grants82274610"],"award-info":[{"award-number":["Grants82274610"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Guizhou Provincial Scientific and Technological Program","award":["Grants Qian Ke He Ji Chu-ZK [2022] General 498"],"award-info":[{"award-number":["Grants Qian Ke He Ji Chu-ZK [2022] General 498"]}]},{"name":"Guizhou Provincial Scientific and Technological Program","award":["Qian Ke He Ji Chu-ZK [2022] General 487"],"award-info":[{"award-number":["Qian Ke He Ji Chu-ZK [2022] General 487"]}]},{"name":"2024 National-Level College Student Innovation and Entrepreneurship Training Project","award":["Project No. 2024106620598"],"award-info":[{"award-number":["Project No. 2024106620598"]}]},{"name":"Research Center for Translational Engineering in the Prevention and Treatment of Tumors with Traditional Chinese Medicine and Ethnomedicine at Guizhou Universities","award":["Document No. Qian Jiaojie [2023]037"],"award-info":[{"award-number":["Document No. Qian Jiaojie [2023]037"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-19590-7","type":"journal-article","created":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T13:47:54Z","timestamp":1760363274000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Investigation of the toxicological effects of PFAS on cholangiocarcinoma based on network toxicology, bioinformatics, and molecular docking"],"prefix":"10.1038","volume":"15","author":[{"given":"Huazheng","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changpu","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangmin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenzhen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ailing","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongxin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,13]]},"reference":[{"key":"19590_CR1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.72239","volume":"16","author":"SR Kale","year":"2024","unstructured":"Kale, S. R. et al. Recent trends in liver cancer: epidemiology, risk factors, and diagnostic techniques. Cureus 16, e72239. https:\/\/doi.org\/10.7759\/cureus.72239 (2024).","journal-title":"Cureus"},{"key":"19590_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2022.100550","volume":"4","author":"JA Goodrich","year":"2022","unstructured":"Goodrich, J. A. et al. Exposure to perfluoroalkyl substances and risk of hepatocellular carcinoma in a multiethnic cohort. JHEP Rep. 4, 100550. https:\/\/doi.org\/10.1016\/j.jhepr.2022.100550 (2022).","journal-title":"JHEP Rep."},{"key":"19590_CR3","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s41370-024-00742-2","volume":"35","author":"S Li","year":"2025","unstructured":"Li, S. et al. Associations between per-and polyfluoroalkyl substances (PFAS) and county-level cancer incidence between 2016 and 2021 and incident cancer burden attributable to PFAS in drinking water in the United States. J. Expo. Sci. Environ. Epidemiol. 35, 425\u2013436. https:\/\/doi.org\/10.1038\/s41370-024-00742-2 (2025).","journal-title":"J. Expo. Sci. Environ. Epidemiol."},{"key":"19590_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2023.115089","volume":"260","author":"N Fujiwara","year":"2023","unstructured":"Fujiwara, N. et al. Perfluorooctanoic acid-induced cell death via the dual roles of ROS-MAPK\/ERK signaling in ameloblast-lineage cells. Ecotoxicol. Environ. Saf. 260, 115089. https:\/\/doi.org\/10.1016\/j.ecoenv.2023.115089 (2023).","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"19590_CR5","doi-asserted-by":"publisher","DOI":"10.1289\/ehp16980","author":"CZ Watling","year":"2025","unstructured":"Watling, C. Z. et al. Circulating per- and polyfluoroalkyl substances and liver cancer risk: a nested case-control analysis of individual participant data from 12 prospective cohorts. Environ. Health Perspect. https:\/\/doi.org\/10.1289\/ehp16980 (2025).","journal-title":"Environ. Health Perspect."},{"key":"19590_CR6","doi-asserted-by":"publisher","first-page":"D1138","DOI":"10.1093\/nar\/gkaa891","volume":"49","author":"AP Davis","year":"2021","unstructured":"Davis, A. P. et al. Comparative toxicogenomics database (CTD): Update 2021. Nucleic Acids Res 49, D1138-d1143. https:\/\/doi.org\/10.1093\/nar\/gkaa891 (2021).","journal-title":"Nucleic Acids Res"},{"key":"19590_CR7","doi-asserted-by":"publisher","first-page":"D1100","DOI":"10.1093\/nar\/gkr777","volume":"40","author":"A Gaulton","year":"2012","unstructured":"Gaulton, A. et al. ChEMBL: A large-scale bioactivity database for drug discovery. Nucleic Acids Res. 40, D1100-1107. https:\/\/doi.org\/10.1093\/nar\/gkr777 (2012).","journal-title":"Nucleic Acids Res."},{"key":"19590_CR8","doi-asserted-by":"publisher","first-page":"W726","DOI":"10.1093\/nar\/gkac297","volume":"50","author":"K Gallo","year":"2022","unstructured":"Gallo, K., Goede, A., Preissner, R. & Gohlke, B. O. SuperPred 3.0 drug classification and target prediction-a machine learning approach. Nucleic Acids Res. 50, W726\u2013W731. https:\/\/doi.org\/10.1093\/nar\/gkac297 (2022).","journal-title":"Nucleic Acids Res."},{"key":"19590_CR9","doi-asserted-by":"publisher","first-page":"D945","DOI":"10.1093\/nar\/gkw1074","volume":"45","author":"A Gaulton","year":"2017","unstructured":"Gaulton, A. et al. The ChEMBL database in 2017. Nucleic Acids Res. 45, D945-d954. https:\/\/doi.org\/10.1093\/nar\/gkw1074 (2017).","journal-title":"Nucleic Acids Res."},{"key":"19590_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0294236","volume":"18","author":"D Tang","year":"2023","unstructured":"Tang, D. et al. SRplot: A free online platform for data visualization and graphing. PLoS ONE 18, e0294236. https:\/\/doi.org\/10.1371\/journal.pone.0294236 (2023).","journal-title":"PLoS ONE"},{"key":"19590_CR11","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"Szklarczyk, D. et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 47, D607-d613. https:\/\/doi.org\/10.1093\/nar\/gky1131 (2019).","journal-title":"Nucleic Acids Res."},{"key":"19590_CR12","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13, 2498\u20132504. https:\/\/doi.org\/10.1101\/gr.1239303 (2003).","journal-title":"Genome Res."},{"key":"19590_CR13","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"W da Huang","year":"2009","unstructured":"da Huang, W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44\u201357. https:\/\/doi.org\/10.1038\/nprot.2008.211 (2009).","journal-title":"Nat. Protoc."},{"key":"19590_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.137971","volume":"283","author":"MZ Ullah","year":"2024","unstructured":"Ullah, M. Z. et al. Exploration of newly synthesized deferasirox derivatives as potential anti-cancer agents via in-vitro and in-silico approaches. Int. J. Biol. Macromol. 283, 137971. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.137971 (2024).","journal-title":"Int. J. Biol. Macromol."},{"key":"19590_CR15","doi-asserted-by":"publisher","first-page":"5998","DOI":"10.1073\/pnas.95.11.5998","volume":"95","author":"DM Tanenbaum","year":"1998","unstructured":"Tanenbaum, D. M., Wang, Y., Williams, S. P. & Sigler, P. B. Crystallographic comparison of the estrogen and progesterone receptor\u2019s ligand binding domains. Proc. Natl. Acad. Sci. U S A 95, 5998\u20136003. https:\/\/doi.org\/10.1073\/pnas.95.11.5998 (1998).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"19590_CR16","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.immuni.2009.04.019","volume":"31","author":"Y Li","year":"2009","unstructured":"Li, Y. et al. Structure of natural killer cell receptor KLRG1 bound to E-cadherin reveals basis for MHC-independent missing self recognition. Immunity 31, 35\u201346. https:\/\/doi.org\/10.1016\/j.immuni.2009.04.019 (2009).","journal-title":"Immunity"},{"key":"19590_CR17","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1021\/jm061152t","volume":"50","author":"M Bruncko","year":"2007","unstructured":"Bruncko, M. et al. Studies leading to potent, dual inhibitors of Bcl-2 and Bcl-xL. J. Med. Chem. 50, 641\u2013662. https:\/\/doi.org\/10.1021\/jm061152t (2007).","journal-title":"J. Med. Chem."},{"key":"19590_CR18","doi-asserted-by":"publisher","first-page":"4421","DOI":"10.1021\/acs.jmedchem.8b00096","volume":"61","author":"E Nuti","year":"2018","unstructured":"Nuti, E. et al. Development of thioaryl-based matrix metalloproteinase-12 inhibitors with alternative zinc-binding groups: synthesis, potentiometric, NMR, and crystallographic studies. J Med Chem 61, 4421\u20134435. https:\/\/doi.org\/10.1021\/acs.jmedchem.8b00096 (2018).","journal-title":"J Med Chem"},{"key":"19590_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41370-018-0094-1","author":"MS Elsie","year":"2018","unstructured":"Elsie, M. S. et al. A review of the pathways of human exposure to poly- and perfluoroalkyl substances (PFASs) and present understanding of health effects. J. Eposure Sci. Environ. Epidemiol. https:\/\/doi.org\/10.1038\/s41370-018-0094-1 (2018).","journal-title":"J. Eposure Sci. Environ. Epidemiol."},{"key":"19590_CR20","doi-asserted-by":"publisher","DOI":"10.1126\/science.abg9065","author":"E Marina","year":"2022","unstructured":"Marina, E. et al. Per- and polyfluoroalkyl substances in the environment. Science https:\/\/doi.org\/10.1126\/science.abg9065 (2022).","journal-title":"Science"},{"key":"19590_CR21","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfm128","author":"L Christopher","year":"2007","unstructured":"Christopher, L. et al. Perfluoroalkyl acids: A review of monitoring and toxicological findings. Toxicol. Sci. https:\/\/doi.org\/10.1093\/toxsci\/kfm128 (2007).","journal-title":"Toxicol. Sci."},{"key":"19590_CR22","doi-asserted-by":"publisher","DOI":"10.1289\/ehp10092","author":"EJ Costello","year":"2022","unstructured":"Costello, E. J. et al. Exposure to per- and polyfluoroalkyl substances and markers of liver injury: A systematic review and meta-analysis. Environ. Health Perspect. https:\/\/doi.org\/10.1289\/ehp10092 (2022).","journal-title":"Environ. Health Perspect."},{"key":"19590_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2022.100550","author":"AG Jesse","year":"2022","unstructured":"Jesse, A. G. et al. Exposure to perfluoroalkyl substances and risk of hepatocellular carcinoma in a multiethnic cohort. JHEP Rep. https:\/\/doi.org\/10.1016\/j.jhepr.2022.100550 (2022).","journal-title":"JHEP Rep."},{"key":"19590_CR24","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-024-03685-7","author":"P Maija","year":"2024","unstructured":"Maija, P. & Kirsi, V. Involvement of per- and polyfluoroalkyl compounds in tumor development. Arch. Toxicol. https:\/\/doi.org\/10.1007\/s00204-024-03685-7 (2024).","journal-title":"Arch. Toxicol."},{"key":"19590_CR25","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1007\/s00204-020-02732-3","volume":"94","author":"AC Behr","year":"2020","unstructured":"Behr, A. C. et al. Impairment of bile acid metabolism by perfluorooctanoic acid (PFOA) and perfluorooctanesulfonic acid (PFOS) in human HepaRG hepatoma cells. Arch. Toxicol. 94, 1673\u20131686. https:\/\/doi.org\/10.1007\/s00204-020-02732-3 (2020).","journal-title":"Arch. Toxicol."},{"key":"19590_CR26","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.envint.2013.06.004","volume":"59","author":"F P\u00e9rez","year":"2013","unstructured":"P\u00e9rez, F. et al. Accumulation of perfluoroalkyl substances in human tissues. Environ. Int. 59, 354\u2013362. https:\/\/doi.org\/10.1016\/j.envint.2013.06.004 (2013).","journal-title":"Environ. Int."},{"key":"19590_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jes.2023.05.026","author":"D Cao","year":"2024","unstructured":"Cao, D. et al. Distribution of per- and polyfluoroalkyl substances in blood, serum, and urine of patients with liver cancer and associations with liver function biomarkers. J. Environ. Sci. https:\/\/doi.org\/10.1016\/j.jes.2023.05.026 (2024).","journal-title":"J. Environ. Sci."},{"key":"19590_CR28","doi-asserted-by":"publisher","first-page":"573","DOI":"10.3390\/life15040573","volume":"15","author":"C Mi\u0161\u013eanov\u00e1","year":"2025","unstructured":"Mi\u0161\u013eanov\u00e1, C. & Valachovi\u010dov\u00e1, M. Health impacts of per- and polyfluoroalkyl substances (PFASs): A comprehensive review. Life 15, 573 (2025).","journal-title":"Life"},{"key":"19590_CR29","unstructured":"Sun, B. et al. Celecoxib as a Potential Treatment for Hepatocellular Carcinoma in Populations Exposed to High PFAS Levels. Journal of Hazardous Materials"},{"key":"19590_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2023.100694","author":"Z Mengjie","year":"2023","unstructured":"Mengjie, Z. et al. Association of per- and polyfluoroalkyl substance exposure with fatty liver disease risk in US adults. JHEP Rep. https:\/\/doi.org\/10.1016\/j.jhepr.2023.100694 (2023).","journal-title":"JHEP Rep."},{"key":"19590_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0245442","author":"L Wen","year":"2021","unstructured":"Wen, L. et al. Perfluorooctane sulfonate induces autophagy-associated apoptosis through oxidative stress and the activation of extracellular signal\u2013regulated kinases in renal tubular cells. PLoS ONE https:\/\/doi.org\/10.1371\/journal.pone.0245442 (2021).","journal-title":"PLoS ONE"},{"key":"19590_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhazmat.2021.127656","volume":"424","author":"Q Huang","year":"2022","unstructured":"Huang, Q. et al. Low-dose perfluorooctanoic acid stimulates steroid hormone synthesis in Leydig cells: Integrated proteomics and metabolomics evidence. J. Hazard Mater. 424, 127656. https:\/\/doi.org\/10.1016\/j.jhazmat.2021.127656 (2022).","journal-title":"J. Hazard Mater."},{"key":"19590_CR33","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1111\/j.1742-4658.2011.08432.x","volume":"279","author":"G Lorbek","year":"2012","unstructured":"Lorbek, G., Lewinska, M. & Rozman, D. Cytochrome P450s in the synthesis of cholesterol and bile acids\u2013from mouse models to human diseases. Febs j 279, 1516\u20131533. https:\/\/doi.org\/10.1111\/j.1742-4658.2011.08432.x (2012).","journal-title":"Febs j"},{"key":"19590_CR34","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.tem.2011.01.003","volume":"22","author":"M Umetani","year":"2011","unstructured":"Umetani, M. & Shaul, P. W. 27-Hydroxycholesterol: the first identified endogenous SERM. Trends Endocrinol. Metab. 22, 130\u2013135. https:\/\/doi.org\/10.1016\/j.tem.2011.01.003 (2011).","journal-title":"Trends Endocrinol. Metab."},{"key":"19590_CR35","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.ecoenv.2019.01.027","volume":"171","author":"H Cao","year":"2019","unstructured":"Cao, H. et al. Protonation state effects of estrogen receptor \u03b1 on the recognition mechanisms by perfluorooctanoic acid and perfluorooctane sulfonate: A computational study. Ecotoxicol. Environ. Saf. 171, 647\u2013656. https:\/\/doi.org\/10.1016\/j.ecoenv.2019.01.027 (2019).","journal-title":"Ecotoxicol. Environ. Saf."},{"issue":"2","key":"19590_CR36","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/cells5020015","volume":"5","author":"MH Park","year":"2016","unstructured":"Park, M. H. & Hong, J. T. Roles of NF-\u03baB in cancer and inflammatory diseases and their therapeutic approaches. Cells 5(2), 15. https:\/\/doi.org\/10.3390\/cells5020015 (2016).","journal-title":"Cells"},{"key":"19590_CR37","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1186\/s12967-025-06517-z","volume":"23","author":"Y Hong","year":"2025","unstructured":"Hong, Y. et al. Decoding per- and polyfluoroalkyl substances (PFAS) in hepatocellular carcinoma: a multi-omics and computational toxicology approach. J Transl Med 23, 504. https:\/\/doi.org\/10.1186\/s12967-025-06517-z (2025).","journal-title":"J Transl Med"},{"key":"19590_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2021.111775","author":"L Ying","year":"2021","unstructured":"Ying, L. et al. Occurrence and distribution of per- and polyfluoroalkyl substances (PFASs) in human livers with liver cancer. Environ. Res. https:\/\/doi.org\/10.1016\/j.envres.2021.111775 (2021).","journal-title":"Environ. Res."},{"key":"19590_CR39","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1111\/liv.15366","volume":"42","author":"M Tanaka","year":"2022","unstructured":"Tanaka, M. et al. KRAS mutation in intrahepatic cholangiocarcinoma: Linkage with metastasis-free survival and reduced E-cadherin expression. Liver Int 42, 2329\u20132340. https:\/\/doi.org\/10.1111\/liv.15366 (2022).","journal-title":"Liver Int"},{"key":"19590_CR40","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1038\/labinvest.2009.89","volume":"89","author":"M Onodera","year":"2009","unstructured":"Onodera, M. et al. Fascin is involved in tumor necrosis factor-alpha-dependent production of MMP9 in cholangiocarcinoma. Lab Invest 89, 1261\u20131274. https:\/\/doi.org\/10.1038\/labinvest.2009.89 (2009).","journal-title":"Lab Invest"},{"key":"19590_CR41","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1186\/s13046-024-03177-7","volume":"43","author":"A Cigliano","year":"2024","unstructured":"Cigliano, A. et al. HSF1 is a prognostic determinant and therapeutic target in intrahepatic cholangiocarcinoma. J Exp Clin Cancer Res 43, 253. https:\/\/doi.org\/10.1186\/s13046-024-03177-7 (2024).","journal-title":"J Exp Clin Cancer Res"},{"key":"19590_CR42","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ccell.2021.12.006","volume":"40","author":"L Dong","year":"2022","unstructured":"Dong, L. et al. Proteogenomic characterization identifies clinically relevant subgroups of intrahepatic cholangiocarcinoma. Cancer Cell 40, 70-87.e15. https:\/\/doi.org\/10.1016\/j.ccell.2021.12.006 (2022).","journal-title":"Cancer Cell"},{"key":"19590_CR43","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s12935-021-01929-5","volume":"21","author":"F Li","year":"2021","unstructured":"Li, F. et al. ESR1 as a recurrence-related gene in intrahepatic cholangiocarcinoma: A weighted gene coexpression network analysis. Cancer Cell Int 21, 225. https:\/\/doi.org\/10.1186\/s12935-021-01929-5 (2021).","journal-title":"Cancer Cell Int"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19590-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19590-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19590-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T13:47:55Z","timestamp":1760363275000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19590-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,13]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["19590"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-19590-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,13]]},"assertion":[{"value":"13 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The public data we used to validate our key genes were sourced from the TCGA, and HPA databases, as cited in our paper. This data was utilized solely for research purposes.This study did not involve prospective clinical decision-making. Any predictive models presented are for research purposes only and require independent validation before clinical application.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"35715"}}